Research and Development

The Research and Development team at Oxford BioTherapeutics is dedicated to advancing innovative therapies for cancer through rigorous scientific exploration and experimental validation. This team conducts cutting-edge research and development of biopharmaceuticals, focusing on antibody-drug conjugates and companion diagnostics, to ensure the efficacy and safety of next-generation cancer treatments. Collaborating across disciplines, they translate scientific findings into actionable insights that drive the company’s therapeutic pipeline forward.